Category stocks

Liminatus Pharma Raises $1.9M

Liminatus Pharma secures $1.9M via warrant exercises Liminatus Pharma has entered into a warrant exercise agreement to raise $1.9M. The company will issue new unregistered warrants to purchase 20.68M shares. The agreement involves the exercise of outstanding warr

Medtronic Q4 Earnings Call Highlights

Key Points - Medtronic posted strong fiscal Q4 and full-year results, with revenue of $9.8 billion in the quarter and $36.4 billion for the year, both above expectations. Management said it was the company’s strongest top-line performance in a decade, driven by growth acro